QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Iovance Biotherapeutics (IOVA) News Today

$15.94
+0.17 (+1.08%)
(As of 02/22/2024 ET)
SourceHeadline
benzinga.com logoIovance Biotherapeutics Unusual Options Activity For February 22
benzinga.com - February 22 at 3:53 PM
globenewswire.com logoIovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024
globenewswire.com - February 22 at 8:45 AM
marketbeat.com logoZacks Research Equities Analysts Cut Earnings Estimates for Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
marketbeat.com - February 22 at 7:19 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Sees Large Volume Increase After Insider Buying Activity
americanbankingnews.com - February 22 at 2:12 AM
realmoney.thestreet.com logoIovance Biotherapeutics price target raised by $4 at Piper Sandler, here's why
realmoney.thestreet.com - February 21 at 7:27 PM
marketbeat.com logoIovance Biotherapeutics (NASDAQ:IOVA) Sees Strong Trading Volume on Insider Buying Activity
marketbeat.com - February 21 at 10:26 AM
msn.com logoIovance Biotherapeutics Stock Rockets 30% Higher
msn.com - February 21 at 9:26 AM
MarketBeat logoIovance Biotherapeutics, Inc. (NASDAQ:IOVA) Director Merrill A. Mcpeak Buys 250,000 Shares of Stock
americanbankingnews.com - February 21 at 4:32 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Given New $25.00 Price Target at JMP Securities
americanbankingnews.com - February 21 at 3:38 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Given New $22.00 Price Target at Wells Fargo & Company
americanbankingnews.com - February 21 at 3:38 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Given New $18.00 Price Target at Piper Sandler
americanbankingnews.com - February 21 at 3:38 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Price Target Raised to $34.00 at Chardan Capital
americanbankingnews.com - February 21 at 3:38 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Price Target Raised to $19.00 at The Goldman Sachs Group
americanbankingnews.com - February 21 at 3:38 AM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Up Following Insider Buying Activity
americanbankingnews.com - February 21 at 2:20 AM
MarketBeat logoInvestors Purchase High Volume of Call Options on Iovance Biotherapeutics (NASDAQ:IOVA)
americanbankingnews.com - February 21 at 1:22 AM
bizjournals.com logoOn heels of cancer cell therapy win, Peninsula biotech looks to raise $211M
bizjournals.com - February 20 at 8:00 PM
za.investing.com logoIovance Biotherapeutics price targets raised following FDA accelerated approval
za.investing.com - February 20 at 2:56 PM
bizjournals.com logoIovance stock soars on FDA approval of its melanoma gene therapy
bizjournals.com - February 20 at 2:56 PM
fool.com logoWhy Iovance Biotherapeutics Stock Is Skyrocketing Today
fool.com - February 20 at 2:56 PM
finance.yahoo.com logoIovance Biotherapeutics Stock Rockets 41% Higher. Here’s Why.
finance.yahoo.com - February 20 at 2:56 PM
marketbeat.com logoIovance Biotherapeutics (NASDAQ:IOVA) PT Raised to $25.00 at JMP Securities
marketbeat.com - February 20 at 1:34 PM
investorplace.com logoWhy Is Iovance Therapeutics (IOVA) Stock Up 35% Today?
investorplace.com - February 20 at 1:02 PM
barrons.com logoIovance Biotherapeutics Stock Rockets 41% Higher. Here's Why.
barrons.com - February 20 at 12:52 PM
marketbeat.com logoInvestors Buy High Volume of Iovance Biotherapeutics Call Options (NASDAQ:IOVA)
marketbeat.com - February 20 at 11:33 AM
fool.com logoWhy Iovance Biotherapeutics Stock Is Skyrocketing Today
fool.com - February 20 at 11:02 AM
marketbeat.com logoIovance Biotherapeutics (NASDAQ:IOVA) Shares Gap Up Following Analyst Upgrade
marketbeat.com - February 20 at 10:17 AM
markets.businessinsider.com logoIovance Prices Public Offering Of $211 Mln Of Shares; Stock Up Over 25% In Pre-market
markets.businessinsider.com - February 20 at 9:56 AM
seekingalpha.com logoIovance Biotherapeutics: Amtagvi's Pioneering Approval Sets New Standards In Melanoma
seekingalpha.com - February 20 at 9:56 AM
finance.yahoo.com logoIovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
finance.yahoo.com - February 20 at 9:56 AM
prnewswire.com logoWuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
prnewswire.com - February 20 at 8:00 AM
globenewswire.com logoIovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
globenewswire.com - February 20 at 6:30 AM
ca.finance.yahoo.com logoIovance Biotherapeutics, Inc. (2LB.F)
ca.finance.yahoo.com - February 19 at 7:00 PM
markets.businessinsider.com logoASTCT Supports the FDA’s Accelerated Approval of AMTAGVI for Treatment of Metastatic Melanoma
markets.businessinsider.com - February 19 at 7:00 PM
finance.yahoo.com logoIovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi
finance.yahoo.com - February 19 at 1:17 PM
msn.com logoFDA Approves New Treatment for Advanced Melanoma
msn.com - February 19 at 8:17 AM
marketbeat.com logoRafferty Asset Management LLC Acquires 443,249 Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
marketbeat.com - February 19 at 7:15 AM
msn.com logoIovance gets FDA accelerated approval for advanced melanoma therapy
msn.com - February 18 at 3:00 PM
MarketBeat logoIovance Biotherapeutics (NASDAQ:IOVA) Hits New 52-Week High at $10.44
americanbankingnews.com - February 18 at 5:34 AM
finanznachrichten.de logoIovance Biotherapeutics, Inc.: Iovance's AMTAGVI (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
finanznachrichten.de - February 17 at 8:18 AM
marketwatch.com logoIovance Says Amtagvi Gets Accelerated Approval for Advanced Melanoma
marketwatch.com - February 16 at 8:35 PM
finance.yahoo.com logoIovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
finance.yahoo.com - February 16 at 8:35 PM
bizjournals.com logoPeninsula biotech Iovance's long road to cancer cell therapy leads to FDA approval
bizjournals.com - February 16 at 8:35 PM
msn.com logoFDA approves new therapy for hard-to-treat metastatic melanoma
msn.com - February 16 at 8:35 PM
seekingalpha.com logoIovance gets FDA accelerated approval for advanced melanoma therapy (update)
seekingalpha.com - February 16 at 8:35 PM
msn.com logoFDA approves groundbreaking treatment for advanced melanoma
msn.com - February 16 at 8:35 PM
globenewswire.com logoIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com - February 16 at 5:30 PM
marketbeat.com logoIovance Biotherapeutics (NASDAQ:IOVA) Sets New 12-Month High at $10.44
marketbeat.com - February 16 at 4:51 PM
reuters.com logoUS FDA grants accelerated approval for Iovance's skin cancer cell therapy
reuters.com - February 16 at 4:07 PM
globenewswire.com logoIovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024
globenewswire.com - February 16 at 3:38 PM
globenewswire.com logoIovance's AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
globenewswire.com - February 16 at 3:19 PM
Get Iovance Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter.



IOVA Media Mentions By Week

IOVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IOVA
News Sentiment

0.61

0.48

Average
Medical
News Sentiment

IOVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IOVA Articles
This Week

60

5

IOVA Articles
Average Week

Get Iovance Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IOVA) was last updated on 2/22/2024 by MarketBeat.com Staff